• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

AADA board approves pathology position statement

The American Academy of Dermatology Association’s board of directors has unanimously approved a position statement on anatomic pathology billing.

 

The American Academy of Dermatology Association’s board of directors has unanimously approved a position statement on anatomic pathology billing.

The AADA’s position statement affirms the right to bill for one’s own work; affirms the principle of freedom of choice of dermatopathology consultants; supports the value of dermatology office labs; and expresses concern about ethical and legal propriety of several practices that place maximizing revenue over patient welfare.

“This statement establishes a strong position on the wide variety of pathology arrangements that exist today,” Daniel M. Siegel, M.D., former AADA president said in a statement. “Members can use this guidance to ensure that they are practicing in the most appropriate way.”

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Videos
© 2025 MJH Life Sciences

All rights reserved.